Cost-per-kit test contract for chemistry immunoassays testing reagent kits
Ended Purchase Order Awarded Last action
- Contract number
- W81K0025PA185
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $1,323,229
Award facts
- Opportunity
-
- Solicitation- Chemistry Immunoassays testing reagents- WBAMC Solicitation · W81K0025QA091 · Posted Jul 16, 2025
- Contract value 54% obligated
- $2,455,184.37 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Fort Bliss, TX 79918, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $79,621 | |
| Funding Only Action | $1,131,955 | |
| Exercise an Option | $0 | |
| Original award | $111,653 |
About this award
The Defense Health Agency awarded a purchase order to Roche Diagnostics Corporation for chemistry immunoassays testing reagent kits with a ceiling value of $2,455,184.37 on September 1, 2025, with completion by September 30, 2027.
Work is performed at Fort Bliss, Texas. The order procures leased chemistry and immunoassay analyzers, modular laboratory equipment including centrifuges and sample handling systems, and reagent kits under a firm fixed-price, cost-per-kit structure. The contract supports the William Beaumont Army Medical Center's clinical laboratory operations, requiring compatibility with existing Sysmex XN9100 hematology systems and capacity to perform over 95 chemistry and immunoassay tests. Performance requirements include 24/7 customer support, emergency repair services within four hours, and remote diagnostics. Contractor must obtain Risk Management Framework certification within 270 days of award. The order originated from Army Medical Command Solicitation W81K00-25-Q-A091 (posted July 16, 2025; deadline August 4, 2025), evaluated under Lowest Price Technically Acceptable criteria with no set-aside designation.
Quick answers
Who was awarded contract W81K0025PA185?
W81K0025PA185 was awarded to Roche Diagnostics Corporation by Medical Command (Department of the Army) on September 1, 2025.
How much is contract W81K0025PA185 worth?
The government has obligated $1,323,229 on W81K0025PA185. Its current value, with exercised options, is $2,455,184.
Which agency awarded contract W81K0025PA185?
Medical Command (Department of the Army) awarded W81K0025PA185, with funding from Defense Health Agency (Department of Defense).
Was contract W81K0025PA185 competed?
The extent of competition for W81K0025PA185 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award